Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

laboratorios hipra s.a. - streptococcus uberis antigen - unknown - streptococcus uberis antigen vaccine-antigen active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

intervet international bv - live deletion-mutant streptococcus equi strain tw928 - immunologicals for equidae - horses - for immunisation of horses against streptococcus equi to reduce clinical signs and occurrence of lymph-node abscesses.onset of immunity: the onset of immunity is established as two weeks after basic vaccination.duration of immunity: the duration of immunity is up to three months.the vaccine is intended for use in horses for which a risk of streptococcus equi infection has been clearly identified, due to contact with horses from areas where this pathogen is known to be present, e.g. stables with horses that travel to shows or competitions in such areas, or stables that obtain or have livery horses from such areas.

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - streptococcus equi - streptococcus equi 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - streptococcus equi; clostridium tetani toxoid - streptococcus equi 0 vaccine; clostridium tetani toxoid 0 vaccine - vaccine

United States - English - NLM (National Library of Medicine)

wyeth pharmaceutical division of wyeth holdings llc - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 54ec0se5pz) (streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:54ec0se5pz), streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 2vf3v7175u) (streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:2vf3v7175u), streptococcus pneumoniae type - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen 2.2 ug in 0.5 ml - in children 6 weeks through 5 years of age (prior to the 6th birthday), prevnar 13® is indicated for: in children 6 years through 17 years of age (prior to the 18th birthday), prevnar 13 is indicated for: risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. available data on prevnar 13 administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. a developmental toxicity study has been performed in female rabbits administered prevnar 13 prior to mating and during gestation. each dose was approximately 20 times the human dose. this study revealed no evidence of harm to the fetus due to prevnar 13 (see 8.1 data). data animal in a developmental toxicity study, female rabbits were administered prevnar 13 by intramuscular injection twice prior to mating (17 days an

United States - English - NLM (National Library of Medicine)

a-s medication solutions - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 54ec0se5pz) (streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:54ec0se5pz), streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen (unii: 2vf3v7175u) (streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen - unii:2vf3v7175u), streptococcus pneumoniae type - streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen 2.2 ug in 0.5 ml - in children 6 weeks through 5 years of age (prior to the 6th birthday), prevnar 13® is indicated for: in children 6 years through 17 years of age (prior to the 18th birthday), prevnar 13 is indicated for: risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. available data on prevnar 13 administered to pregnant women are insufficient to inform vaccine-associated risks in pregnancy. a developmental toxicity study has been performed in female rabbits administered prevnar 13 prior to mating and during gestation. each dose was approximately 20 times the human dose. this study revealed no evidence of harm to the fetus due to prevnar 13 (see 8.1 data). data animal in a developmental toxicity study, female rabbits were administered prevnar 13 by intramuscular injection twice prior to mating (17 days an

Philippines - English - FDA (Food And Drug Administration)

virbac philippines inc.; distributor: virbac philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , mycoplasma hyopneumoniae , streptococcus suis , haemophilus parasuis vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), cinnamic acid (unii: u14a832j8d) (cinnamic acid - unii:u14a832j8d), escherichia coli (unii: 514b9k0l10) (escherichia coli - unii:514b9k0l10), herring sperm dna (unii: 51fi676n6f) (herring sperm dna - unii:51fi676n6f), shigella dysenteriae (unii: 1ep6r5562j) (shigella dysenteriae - unii:1ep6r5562j), echinacea angustifolia whole (unii: vb06av5us8) (echinacea angustifolia - unii:vb06av5us8), enterococcus faecalis (unii: 15e04lz9ct) (enterococcus faecalis - unii:15e04lz9ct), helicobacter pylori (unii: u09w5jol3z) (helicobacter pylori - unii:u09w5jol3z), helicobacter pylori dna (unii: 14zy3jp7m6) (helicobacter pylori dna - unii:14zy3jp7m6), legionella pneumophila (unii: tjr6zfy0f0) (legionella pneumophila - unii:tjr6zfy0f0), listeria monocytogenes (unii: 3o44k14a86) (listeria monocytogenes - unii:3o44k14a86), malic acid (unii: 817l1n4ckp) (malic acid - unii:817l1n4ckp), mycoplasma pneumoniae (unii: jqe470fad0) (mycoplasma pneumoniae - unii:jqe470fad0), sodium diethyl oxalacetate (unii: 6ca025y4fg) (diethyl oxalacetate - unii:15s56468g7), orotic acid monohydrate (unii: 91532s02ao) (orotic acid - unii:61h4t033e5), petroselinum crispum whole (unii: 1wza4y92ex) (petroselinum crispum - unii:1wza4y92ex), streptococcus pneumoniae (unii: bt6u234yr2) (streptococcus pneumoniae - unii:bt6u234yr2), proteus mirabilis (unii: c177vr41dv) (proteus mirabilis - unii:c177vr41dv), proteus morganii (unii: 56x6lid5zy) (proteus morganii - unii:56x6lid5zy), proteus vulgaris (unii: 11t9hco30o) (proteus vulgaris - unii:11t9hco30o), pseudomonas aeruginosa (unii: y793w5v55n) (pseudomonas aeruginosa - unii:y793w5v55n), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), salmonella enterica enterica serovar typhi (unii: 760t5r8b3o) (salmonella enterica enterica serovar typhi - unii:760t5r8b3o), shigella sonnei (unii: oo358e3009) (shigella sonnei - unii:oo358e3009), streptococcus agalactiae (unii: 2b3763s671) (streptococcus agalactiae - unii:2b3763s671), streptococcus equinus (unii: r2p4nkp3zk) (streptococcus equinus - unii:r2p4nkp3zk), streptococcus dysgalactiae (unii: ln0sh02y5m) (streptococcus dysgalactiae - unii:ln0sh02y5m), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j33mjj1), streptococcus uberis (unii: o84v4zk4bx) (streptococcus uberis - unii:o84v4zk4bx), streptococcus viridans group (unii: nnv2379hkr) (streptococcus viridans group - unii:nnv2379hkr) - adenosinum triphosphoricum dinatrum – mucus congestion, cinnamic acid – bladder discomfort, colibacillinum cum natrum muriaticum – stomach discomfort, dna joint discomfort, dysentery bacillus - fever, echinacea (angustifolia) - headache, enterococcus faecalis – mucus congestion, helicobacter pylori – stomach discomfort, helicobacter pylori dna – stomach discomfort, legionella pneumophila - cough, listeria monocytogenes – occasional diarrhea, malicum acidum – joint discomfort, mycoplasma pneumoniae – mucus congestion, natrum oxalaceticum – bladder discomfort, oroticum acidum – stomach discomfort, petroselinum sativum – fever, pneumococcinum - headache, proteus (mirabilis) – mucus congestion, proteus (morgani) – stomach discomfort, proteus (vulgaris) – bladder discomfort, pseudomonas aeruginosa – fever, riboflavinum – headache, salmonella typhi nosode – stomach discomfort, shigella sonnei – occasional diarrhea, streptococcus agalactiae - couch, streptococcus bovis – joint discomfort, streptococcus dysgalactiae – joint discomfort, streptococcus mutans - fever, streptococcus uberis – fever, streptococcus viridans – fever • for the temporary relief of symptoms including: • mucus congestion • stomach discomfort • fever • headache • cough • joint discomfort • occasional diarrhea • bladder discomfort these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Philippines - English - FDA (Food And Drug Administration)

virbac philippines inc.; distributor: virbac philippines inc. - inactivated streptococcus agalactiae fish vaccine (vet.) - emulsion for injection (ip) - formulation: each 0.1 ml (dose) contains: streptococcus agalactiae scrotype lb (ti098 strain) ≥ 1.8 x 108 cfu cfu - colony forming unit

Philippines - English - FDA (Food And Drug Administration)

virbac philippines inc.; distributor: virbac philippines inc. - inactivated streptococcus agalactiae ser. ia, ib, iii fish vaccine (vet.) - emulsion for injection (ip) - each 0.1 ml (dose) contains: streptococcus agalactiae serotype ib (t1098 strain)≥ 1.8 x 108 cfu streptococcus agalactiae serotype ia (ti191 strain)≥ 1.8 x 108 cfu streptococcus agalactiae serotype iii (ti198 strain) ≥ 1.8 x 108 cfu cfu - colony forming unit